Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2007

01-08-2007 | Case Report

First confirmed autochthonous case of human Babesia microti infection in Europe

Authors: A. Hildebrandt, K.-P. Hunfeld, M. Baier, A. Krumbholz, S. Sachse, T. Lorenzen, M. Kiehntopf, H.-J. Fricke, E. Straube

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2007

Login to get access

Abstract

A 42-year-old female patient with acute myeloid leukemia presented with fever and heavy chest pain after her first cycle of specific chemotherapy. Acute myocardial infarction was excluded, but surprisingly, parasitic inclusions in erythrocytes became obvious in Pappenheim and Giemsa-stained peripheral blood smears. The patient did not remember a tick bite but acknowledged having received several blood transfusions in her recent medical history. Suspicion of malaria was ruled out by use of a dip-stick test. The diagnosis of Babesia microti infection was finally established by specific polymerase chain reaction (PCR). Six weeks after initiation of specific treatment, PCR turned negative and a positive immunoflourescence assay (IFA) with an IgG titer of 1:128 indicated seroconversion. Subsequent screening of donors involved in the transfusion of blood products to the patient demonstrated borderline reactivity for Babesia microti (IgG-titer 1:32) in 1 out of 44 individuals. Neither the patient nor the positively tested blood donor had travelled to North America or Asia. Therefore, this is the first confirmed autochthonous human infection in Europe.
Literature
1.
go back to reference Homer MJ, Aguilar-Delfin I, Telford SR 3rd, Krause PJ, Persing DH (2000) Babesiosis. Clin Microbiol Rev 13(3):451–469PubMedCrossRef Homer MJ, Aguilar-Delfin I, Telford SR 3rd, Krause PJ, Persing DH (2000) Babesiosis. Clin Microbiol Rev 13(3):451–469PubMedCrossRef
2.
go back to reference Skrabalo Z, Deanovic Z (1957) Piroplasmosis in man; report of a case. Doc Med Geogr Trop 9(1):11–16PubMed Skrabalo Z, Deanovic Z (1957) Piroplasmosis in man; report of a case. Doc Med Geogr Trop 9(1):11–16PubMed
3.
go back to reference Conrad PA, Kjemtrup AM, Carreno RA, Thomford J, Wainwright K, Eberhard M, Quick R, Telford SR 3rd, Herwaldt BL (2006) Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 36(7):779–789PubMedCrossRef Conrad PA, Kjemtrup AM, Carreno RA, Thomford J, Wainwright K, Eberhard M, Quick R, Telford SR 3rd, Herwaldt BL (2006) Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 36(7):779–789PubMedCrossRef
4.
go back to reference Herwaldt BL, Caccio S, Gherlinzoni F, Aspock H, Slemenda SB, Piccaluga P, Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Loschenberger K, Tura S, Pieniazek NJ (2003) Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 9(8):942–948PubMed Herwaldt BL, Caccio S, Gherlinzoni F, Aspock H, Slemenda SB, Piccaluga P, Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Loschenberger K, Tura S, Pieniazek NJ (2003) Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis 9(8):942–948PubMed
5.
go back to reference Gray JS (2006) Identity of the causal agents of human babesiosis in Europe. Int J Med Microbiol 296(Suppl 40):131–136PubMedCrossRef Gray JS (2006) Identity of the causal agents of human babesiosis in Europe. Int J Med Microbiol 296(Suppl 40):131–136PubMedCrossRef
6.
go back to reference Hunfeld KP, Brade V (2004) Zoonotic Babesia: possibly emerging pathogens to be considered for tick-infested humans in Central Europe. Int J Med Microbiol 293(Suppl 37):93–103PubMed Hunfeld KP, Brade V (2004) Zoonotic Babesia: possibly emerging pathogens to be considered for tick-infested humans in Central Europe. Int J Med Microbiol 293(Suppl 37):93–103PubMed
7.
8.
go back to reference Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP (1998) Human babesiosis. Ann Trop Med Parasitol 92(4):489–501PubMedCrossRef Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP (1998) Human babesiosis. Ann Trop Med Parasitol 92(4):489–501PubMedCrossRef
10.
go back to reference Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, Tenter AM (2002) Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol 40(7):2431–2436PubMedCrossRef Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, Tenter AM (2002) Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol 40(7):2431–2436PubMedCrossRef
11.
go back to reference Foppa IM, Krause PJ, Spielman A, Goethert H, Gern L, Brand B, Telford SR 3rd (2002) Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland. Emerg Infect Dis 8(7):722–726PubMed Foppa IM, Krause PJ, Spielman A, Goethert H, Gern L, Brand B, Telford SR 3rd (2002) Entomologic and serologic evidence of zoonotic transmission of Babesia microti, eastern Switzerland. Emerg Infect Dis 8(7):722–726PubMed
12.
go back to reference Walter G, Weber G (1981) A study on the transmission (transstadial, transovarial) of Babesia microti, strain “Hannover i”, in its tick vector, Ixodes ricinus (author’s transl). Tropenmed Parasitol 32(4):228–230PubMed Walter G, Weber G (1981) A study on the transmission (transstadial, transovarial) of Babesia microti, strain “Hannover i”, in its tick vector, Ixodes ricinus (author’s transl). Tropenmed Parasitol 32(4):228–230PubMed
13.
go back to reference Piesman J, Karakashian SJ, Lewengrub S, Rudzinska MA, Spielmank A (1986) Development of Babesia microti sporozoites in adult Ixodes dammini. Int J Parasitol 16(4):381–385PubMedCrossRef Piesman J, Karakashian SJ, Lewengrub S, Rudzinska MA, Spielmank A (1986) Development of Babesia microti sporozoites in adult Ixodes dammini. Int J Parasitol 16(4):381–385PubMedCrossRef
14.
go back to reference Hartelt K, Oehme R, Frank H, Brockmann SO, Hassler D, Kimmig P (2004) Pathogens and symbionts in ticks: prevalence of Anaplasma phagocytophilum (Ehrlichia sp.), Wolbachia sp., Rickettsia sp., and Babesia sp. in southern Germany. Int J Med Microbiol 293(Suppl 37):86–92PubMed Hartelt K, Oehme R, Frank H, Brockmann SO, Hassler D, Kimmig P (2004) Pathogens and symbionts in ticks: prevalence of Anaplasma phagocytophilum (Ehrlichia sp.), Wolbachia sp., Rickettsia sp., and Babesia sp. in southern Germany. Int J Med Microbiol 293(Suppl 37):86–92PubMed
15.
go back to reference Michel H, Wilske B, Hettche G, Gottner G, Heimerl C, Reischl U, Schulte-Spechtel U, Fingerle V (2004) An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (Berl) 193(4):219–226CrossRef Michel H, Wilske B, Hettche G, Gottner G, Heimerl C, Reischl U, Schulte-Spechtel U, Fingerle V (2004) An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (Berl) 193(4):219–226CrossRef
16.
go back to reference Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS (2003) Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 16(4):622–636PubMedCrossRef Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS (2003) Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 16(4):622–636PubMedCrossRef
17.
go back to reference Meer-Scherrer L, Adelson M, Mordechai E, Lottaz B, Tilton R (2004) Babesia microti infection in Europe. Curr Microbiol 48(6):435–437PubMedCrossRef Meer-Scherrer L, Adelson M, Mordechai E, Lottaz B, Tilton R (2004) Babesia microti infection in Europe. Curr Microbiol 48(6):435–437PubMedCrossRef
18.
go back to reference Telford S, Maguire JH (2006) Babesiosis. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases: principles, pathogens, and practice. Churchill Livingstone, Philadelphia pp 1063–1071 Telford S, Maguire JH (2006) Babesiosis. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases: principles, pathogens, and practice. Churchill Livingstone, Philadelphia pp 1063–1071
19.
go back to reference Krause PJ, Spielman A, Telford SR 3rd, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH (1998) Persistent parasitemia after acute babesiosis. N Engl J Med 339(3):160–165PubMedCrossRef Krause PJ, Spielman A, Telford SR 3rd, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH (1998) Persistent parasitemia after acute babesiosis. N Engl J Med 339(3):160–165PubMedCrossRef
20.
go back to reference Wilske B, Zöller L, Brade V, Eiffert M, Göbel UB, Stanek G, in cooperation with Pfister HW (2000) MIQ 12 Lyme-Borreliose. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. München, Urban and Fischer Wilske B, Zöller L, Brade V, Eiffert M, Göbel UB, Stanek G, in cooperation with Pfister HW (2000) MIQ 12 Lyme-Borreliose. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. München, Urban and Fischer
21.
go back to reference Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, Hewett M, Lin Z, Liu Y, Liu S, Oliver DE, Rubin DL, Shafa F, Stuart JM, Altman RB (2001) Integrating genotype and phenotype information: an overview of the PharmGKB Project. Pharmacogenomics J 1(3):167–170PubMed Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, Hewett M, Lin Z, Liu Y, Liu S, Oliver DE, Rubin DL, Shafa F, Stuart JM, Altman RB (2001) Integrating genotype and phenotype information: an overview of the PharmGKB Project. Pharmacogenomics J 1(3):167–170PubMed
22.
go back to reference Saito-Ito A, Tsuji M, Wei Q, He S, Matsui T, Kohsaki M, Arai S, Kamiyama T, Hioki K, Ishihara C (2000) Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol 38(12):4511–4516PubMed Saito-Ito A, Tsuji M, Wei Q, He S, Matsui T, Kohsaki M, Arai S, Kamiyama T, Hioki K, Ishihara C (2000) Transfusion-acquired, autochthonous human babesiosis in Japan: isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol 38(12):4511–4516PubMed
23.
go back to reference Homer MJ, Bruinsma ES, Lodes MJ, Moro MH, Telford S 3rd, Krause PJ, Reynolds LD, Mohamath R, Benson DR, Houghton RL, Reed SG, Persing DH (2000) A polymorphic multigene family encoding an immunodominant protein from Babesia microti. J Clin Microbiol 38(1):362–368PubMed Homer MJ, Bruinsma ES, Lodes MJ, Moro MH, Telford S 3rd, Krause PJ, Reynolds LD, Mohamath R, Benson DR, Houghton RL, Reed SG, Persing DH (2000) A polymorphic multigene family encoding an immunodominant protein from Babesia microti. J Clin Microbiol 38(1):362–368PubMed
24.
go back to reference Cable RG, Leiby DA (2003) Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases. Curr Opin Hematol 10(6):405–411PubMedCrossRef Cable RG, Leiby DA (2003) Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases. Curr Opin Hematol 10(6):405–411PubMedCrossRef
Metadata
Title
First confirmed autochthonous case of human Babesia microti infection in Europe
Authors
A. Hildebrandt
K.-P. Hunfeld
M. Baier
A. Krumbholz
S. Sachse
T. Lorenzen
M. Kiehntopf
H.-J. Fricke
E. Straube
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0333-1

Other articles of this Issue 8/2007

European Journal of Clinical Microbiology & Infectious Diseases 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine